← Eichor
Condition: Chemotherapy Induced Nausea And Vomiting Cinv Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chemotherapy Induced Nausea And Vomiting Cinv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan
Phase 3 · 1 location(s) · Augusta University · NCT06588413Fosrolapitant Combined With Palonosetron to Prevent Trastuzumab Rezetecan Related CINV
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07726433Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
Phase N/A · 1 location(s) · Anhui Provincial Children's Hospital · NCT06756022A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Phase 2 · 67 location(s) · Eli Lilly and Company · NCT07169851Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paedia
Phase 2 · 20 location(s) · Helsinn Healthcare SA · NCT06904235An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing
Phase 4 · 1 location(s) · Shanghai 6th People's Hospital · NCT07482891Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regim
Phase 3 · 1 location(s) · The Affiliated People's Hospital of Ningbo University · NCT07413809
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.